Content about National Institute of Mental Health

July 30, 2012
Mental health, medicines 
top of mind for industry

In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.


May 23, 2011
Patients, gov’t benefit from generic SSRI, SNRI adherence

The $290 billion that poor medication adherence costs the U.S. economy every year cuts across every imaginable disease state, but one in which it can be particularly problematic is mental health.


© 2013 Drug Store News. All Rights Reserved.